Search Results - "Bertolini, Alessandro S"

Exploring clinical and gene expression markers of benefit from FOLFOXIRI/bevacizumab in patients with BRAF-mutated metastatic colorectal cancer: Subgroup analyses of the TRIBE2 study by Moretto, Roberto, Giordano, Mirella, Poma, Anello M., Passardi, Alessandro, Boccaccino, Alessandra, Pietrantonio, Filippo, Tomasello, Gianluca, Aprile, Giuseppe, Lonardi, Sara, Conca, Veronica, Granetto, Cristina, Frassoldati, Antonio, Clavarezza, Matteo, Bertolini, Alessandro S., Germani, Marco M., Ugolini, Clara, Fontanini, Gabriella, Masi, Gianluca, Falcone, Alfredo, Cremolini, Chiara

“…Recent data from the TRIBE2 study have failed to suggest a higher magnitude of benefit from upfront FOLFOXIRI/bevacizumab in patients with BRAF-mutant…”
Get full text

Abstract P5-14-01: Eribulin tolerability and correlation between neuropathy and a set of polymorphisms in metastatic breast cancer patients. Results from the PAINTER (Polymorphism And Incidence of Toxicity in ERibulin treatment) study by La Verde, Nicla, Damia, Giovanna, Garrone, Ornella, D'Onofrio, Loretta, Fabi, Alessandra, Ciccarese, Mariangela, Generali, Daniele, Nunzi, Martina, Poletto, Elena, Pedrazzoli, Paolo, Cretella, Elisabetta, Scandurra, Giuseppa, Meattini, Icro, Bertolini, Alessandro S, Cavanna, Luigi, Romagnoli, Emanuela, Legramandi, Lorenzo, Guffanti, Federica, Rulli, Eliana, Moretti, Anna, Bocci, Barbara, Farina, Gabriella

“…BACKGROUND: Metastatic breast cancer (MBC) is an incurable disease and its treatment focuses mainly on prolonging patients (pts) survival and improving their…”
Get full text